Chronic Neurology in COVID-19 Era: Clinical Considerations and Recommendations From the REPROGRAM Consortium

Chronic Neurology in COVID-19 Era: Clinical Considerations and Recommendations From the REPROGRAM Consortium
复制标题

DOI:
10.3389/fneur.2020.00664
复制
发表时间:
2020-06-24
影响因子:
3.4
通讯作者:
Mederer Hengstl, Susana
Mederer Hengstl, Susana
中科院分区:
医学3区
文献类型:
--
作者:
Bhaskar, Sonu;Bradley, Sian;Mederer Hengstl, Susana

文献摘要

被引文献

相似文献

随着新出现的冠状病毒2019(新冠肺炎)大流行的快速步伐和规模,越来越多的证据表明新冠肺炎与神经系统前后并发症有很强的相关性。这就需要为这一亚群患者纳入有针对性的神经护理,这需要进一步重组服务、医疗保健人员和持续管理慢性神经病例。社会距离和多个国家在新冠肺炎上强加的关闭严重影响了多发性硬化症、癫痫、神经肌肉疾病、偏头痛、痴呆症和帕金森病等慢性神经系统疾病患者的持续护理、获得和支持。迫切需要包括国家和国际专业协会、卫生部和卫生机构在内的理事机构协调与慢性神经系统疾病管理有关的政策、指导方针和建议。这些协调一致的指南应确保患者在医院和社区护理范围内的连续性,包括患者、他们的护理伙伴和相关卫生专业人员的福祉、安全和心理健康。本文深入分析新冠肺炎对慢性神经系统疾病的影响,并提出具体建议,以最大限度地减少对高危人群的潜在伤害。
With the rapid pace and scale of the emerging coronavirus 2019 (COVID-19) pandemic, a growing body of evidence has shown a strong association of COVID-19 with pre- and post- neurological complications. This has necessitated the need to incorporate targeted neurological care for this subgroup of patients which warrants further reorganization of services, healthcare workforce, and ongoing management of chronic neurological cases. The social distancing and the shutdown imposed by several nations in the midst of COVID-19 have severely impacted the ongoing care, access and support of patients with chronic neurological conditions such as Multiple Sclerosis, Epilepsy, Neuromuscular Disorders, Migraine, Dementia, and Parkinson disease. There is a pressing need for governing bodies including national and international professional associations, health ministries and health institutions to harmonize policies, guidelines, and recommendations relating to the management of chronic neurological conditions. These harmonized guidelines should ensure patient continuity across the spectrum of hospital and community care including the well-being, safety, and mental health of the patients, their care partners and the health professionals involved. This article provides an in-depth analysis of the impact of COVID-19 on chronic neurological conditions and specific recommendations to minimize the potential harm to those at high risk.